|
Robert D. Casale joined Adams Respiratory Therapeutics in May of 2004 as vice president, business development and consumer marketing. Bob was named executive vice president, chief marketing and development officer in May 2005. In October 2006, Bob was promoted to chief operating officer.
Beginning in 1986, Bob served in many capacities at the former Warner-Lambert Company. Most recently, he served as vice president, business development and strategic planning, for Pfizer, Inc., and led development of a strategic plan for the newly merged Pfizer and Warner-Lambert consumer businesses.
Bob began his career at Warner-Lambert in their legal division, and later became lead counsel for Parke-Davis, the company's pharmaceutical business. He also served as lead counsel for the parent company on all acquisitions, merger, and licensing transactions. Subsequently, he was appointed Warner-Lambert's vice president of marketing for upper respiratory and gastrointestinal (GI) consumer products, including Benadryl�, Sudafed�, Zantac 75�, and Rolaids�. Bob also served as a global vice president for Warner-Lambert's GI and skin care businesses.
Bob received a bachelor's degree in business administration and English from Rutgers College in 1980 and a juris doctorate, with honors, from the Rutgers Law School in 1983. | 